Another effort, using the concept that continual treatment of androgen deprivation therapy can select resistant phenotypes and encourage treatment resistance (Zhang et al. 2017), modeled PSA dynamics to predict prostate cancer patient responses to IAS (Brady-Nicholls et al. 2020). The gene discussed is KLK3; the disease is prostate carcinoma.